MOLEQLAR
PrivateLast Round
Seed
Nov 9, 2023
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MOLEQLAR operates in Consumer & Commerce and is based in Berlin. Its latest recorded funding round was a Seed round in November 2023.
MOLEQLAR is a biotechnology and food company that develops and distributes science-based longevity products including nutritional supplements and health tests.
Sector
Consumer & Commerce
Verticals
D2C Brands, Subscription Commerce, Precision Medicine, Biotechnology, E-commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOLEQLAR Comparables
Compare MOLEQLAR with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Purovitalis | 88% | |
| AVEA Life | 85% | |
| DoNotAge | 85% |
For institutional investors. Book with your work email.
MOLEQLAR Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MOLEQLAR Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rheingau Founders | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Open roles increased to 25, 156% of headcount.
- Jun 15, 2026
Open roles increased from 0 to 4, representing 25% of headcount.
For institutional investors. Book with your work email.
MOLEQLAR Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MOLEQLAR's valuation, stock price, and market status.
Is MOLEQLAR a public or private company?
MOLEQLAR is a private company.
What is the current stock price of MOLEQLAR?
MOLEQLAR is a private company, so its shares have no public market price. Caplight tracks MOLEQLAR's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MOLEQLAR worth (valuation)?
Valuation information for MOLEQLAR is not publicly available.
Can I buy MOLEQLAR stock?
MOLEQLAR shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MOLEQLAR's last funding round?
MOLEQLAR's most recent funding round was Seed on November 9, 2023.
Who are the main investors in MOLEQLAR?
Key investors in MOLEQLAR include Rheingau Founders.
Will MOLEQLAR IPO soon?
No public IPO plans have been announced for MOLEQLAR.
How can I track MOLEQLAR secondary market activity?
Caplight tracks bids, offers, and trades in MOLEQLAR's shares on secondary markets.